Parnassus Investments highlights PRVS’s AI-fueled gains and value tilt amid high valuations. See how disciplined stock ...

GSK plc’s strong oncology growth, highlighted by Ojjaara sales and an upgraded 2025 outlook, earns a continued 'Buy' rating.

The company's exposure to data center spending and the "electrification of everything" megatrend is exciting investors.

AstraZeneca Plc's suspension of its COVID-19 vaccine trials after a participant's unexplained illness did not mean the vaccine had been scrapped and showed safety standards were being adhered to, ...

Rank Group plc ( ($GB:RNK) ) just unveiled an announcement. Rank Group plc reported a 9% increase in like-for-like Net Gaming Revenue (NGR) for ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

While SNAP payments and food safety inspections continue, disaster payments, farm loans and federal workers’ pay are on hold ...

Tuesday’s moves mark a third day of market swings, with fears of an escalation in US–China tensions returning to the ...

HR execs have long wanted to be a bigger part of the strategic decision-making process. Is their wish about to come true?

After this recent surge, is STX still a viable purchase – or is it time to secure profits? Dive deeper with Buy or Sell STX.

Globally, the power sector is grappling with severe transformer shortages, driven by fragmented supply chains and ...

By clicking a retailer link you consent to third-party cookies that track your onward journey. This enables W? to receive an ...